Jane Street’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
VCM
VPM
AI
Jane Street's BIO Position: Q1 2026 in Review
Jane Street sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 73,967 shares — an estimated $21.3M sold.
Jane Street first reported a position in BIO in Q3 2013 and held it in 37 quarters. The position peaked at $22.4M in Q4 2025. 392 funds tracked by Wall St. Rank hold BIO as of Q1 2026.
- Jane Street reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 73,967 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $21.3M.
- Jane Street first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and held it in 37 quarters.
- Jane Street's Bio-Rad Laboratories Class A position peaked at $22.4M in Q4 2025.
- 392 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.